Have a personal or library account? Click to login
Study of Mutagenic and Antitoxic Properties of Gentabiferon-B Cover

Study of Mutagenic and Antitoxic Properties of Gentabiferon-B

Open Access
|Mar 2022

References

  1. 1. Miroshnikova, M.S. (2021). Study of the potentiated effect of antimicrobial drugs against probiotic strains of microorganisms. Izvestia Orenburg State Agrarian University 2(88): 168-173. [in Russian] https://doi.org/10.37670/2073-0853-2021-88-2-168-17310.37670/2073-0853-2021-88-2-168-173
  2. 2. Vostroilova, G.A., Shakhov, A.G., Shabunin, S.V., Sashnina, L.Yu., Parshin, P.A., Cheskidova, L.V., Kantorovich, Yu.A. (2018). Сorrective influence of hentabiferon-С on the immune status of post-weaned piglets snd its rffectiveness in the prevention of intestinal infections. Russ Agric Sci. 6, 58-61.
  3. 3. Cheskidova, L.V., Briukhova, I.V., Grigoreva, N.A. (2019). Advanced research directions of creation of new generation medicines for animals with application of biotechnologies (Review). Bulletin Vet Pharmacol. 2(7): 29-38. [in Russian] https://doi.org/10.17238/issn2541-8203.2019.2.2910.17238/issn2541-8203.2019.2.29
  4. 4. Mironov, A.N., Bunatyan, N.D., Vasil’ev, A.N., Verstakova, O.L., Zhuravleva, M.V., Lepahin, V.K., Korobov, N.V., et al. (2012). Guidelines for conducting preclinical studies of drugs. Part one. p. 944. Moscow, Russia: Grief and K
  5. 5. Engalycheva, G.N., Syubaev, R.D., Goryachev, D.V. (2019). Quality standards of preclinical pharmacological studies. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 9(4): 248-255. https://doi.org/10.30895/1991-2919-2019-9-4-248-25510.30895/1991-2919-2019-9-4-248-255
  6. 6. Parlakpinar, H., Tasdemir, S., Polat, A., Bay-Karabulut, A., Vardi, N., Ucar, M., Yanilmaz, M., Kavakli, A., Acet, A. (2006). Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochem Funct. 24(1):41-48. https://doi.org/10.1002/cbf.1182 PMid:1558409110.1002/cbf.1182
  7. 7. Gozhenko, A.I., Vladimirova, M.P., Topor, E.A. (2005). Renal dysfunctions in white rats after a single administration of gentamicin. Nephrology. 9(4): 75-79. [in Russian]
  8. 8. Hosaka, E.M., Santos, O.F.P., Seguro, A.C., Vattimo, M.F.F. (2004). Effect of cyclooxygenase inhibitors on gentamicin induced nephrotoxicity in rats. Braz J Med Biol Res. 37(7): 979-985. https://doi.org/10.1590/S0100-879X2004000700006 PMid: 1526400410.1590/S0100-879X2004000700006
  9. 9. Durnev, A.D. (2018). Antimutagenesis and antimutagens. Hum Physiol. 44(3): 116-137. [in Russian] https://doi.org/10.1134/S036211971803005210.1134/S0362119718030052
  10. 10. Horisberger, M.A., de Staritzky, K. (1987). A recombinant human interferon-alpha B/D hybrid with a broad host-range. J Gen Virol. 68(Pt 3): 945-948. https://doi.org/10.1099/0022-1317-68-3-945 PMid:302931510.1099/0022-1317-68-3-945
  11. 11. Martal, J.L., Chêne, N.M., Huynh, L.P., L’Haridon, R.M., Reinaud, P.B., Guillomot, M.W., Charlier, M.A., Charpigny, S.Y. (1998). IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 80(8-9): 755-777. https://doi.org/10.1016/S0300-9084(99)80029-710.1016/S0300-9084(99)80029-7
  12. 12. Blankenstein, T., Qin, Z. (2003). The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis. Curr Opin Immunol. 15(2): 148-154. https://doi.org/10.1016/S0952-7915(03)00007-410.1016/S0952-7915(03)00007-4
  13. 13. Makedonov, G.P., Chekova, V.V., Yakubovskaya, E.L., Zasukhina, G.D. (1990). Modification of DNA repair by human interferons. Acta Biol Hung. 41(1-3): 187-197.
  14. 14. Kumari, S., Naik, P., Vishma, B.L., Salian, S.R., Devkar, R.A., Khan, S., Mutalik, S., Kalthur, G., Adiga, S.K. (2016). Mitigating effect of Indian propolis against mitomycin C induced bone marrow toxicity. Cytotechnology 68(5): 1789-1800. https://doi.org/10.1007/s10616-015-9931-4 PMid:26590833 PMCid:PMC502355210.1007/s10616-015-9931-4502355226590833
  15. 15. Sinitsky, M.Y., Kutikhin, A.G., Tsepokina, A.V., Shishkova, D.K., Asanov, M.A., Yuzhalin, A.E., Minina, V.I., Ponasenko, A.V. (2020). Mitomycin C induced genotoxic stress in endothelial cells is associated with differential expression of proinflammatory cytokines. Mutat Res Genet Toxicol Environ Mutagen. 858-860: 503252. https://doi.org/10.1016/j.mrgentox.2020.503252 PMid:3319893310.1016/j.mrgentox.2020.50325233198933
  16. 16. Hayashi, M. (2016). The micronucleus test-most widely used in vivo genotoxicity test. Genes Environ. 38, 18. https://doi.org/10.1186/s41021-016-0044-x PMid:27733885 PMCid:PMC504562510.1186/s41021-016-0044-x504562527733885
  17. 17. Agarwal, D.K., Chauhan, L.K. (1993). An improved chemical substitute for fetal calf serum for the micronucleus test. Biotech Histochem. 68(4): 187-188. https://doi.org/10.3109/10520299309104695 PMid:821857010.3109/105202993091046958218570
  18. 18. The European agency for the evaluation of medicinal products, veterinary medicines and inspections (2001). Committee for veterinary medicinal products. Gentamicin summary report. EMEA/MRL/803/01-FINAL. November 2001. 1-9. https://www.ema.europa.eu/en/documents/mrl-report/gentamicin-summary-report-3-committee-veterinary-medicinal-products_en.pdf
  19. 19. El-Ashmawy, I.M., El-Nahas, A.F., Salama, O.M. (2006). Grape seed extract prevents gentamicin-induced nephrotoxicity and genotoxicity in bone marrow cells of mice. Basic Clin Pharmacol Toxicol. 99(3): 230-236. https://doi.org/10.1111/j.1742-7843.2006.pto_497.x PMid:1693029610.1111/j.1742-7843.2006.pto_497.x16930296
  20. 20. Velasco-Velázquez, M.A., Maldonado, P.D., Barrera, D., Torres, V., Zentella-Dehesa, A., Pedraza-Chaverrí, J. (2006). Aged garlic extract induces proliferation and ameliorates gentamicin-induced toxicity in LLC-PK1 cells. Phytother Res. 20(1): 76-78. https://doi.org/10.1002/ptr.1780 PMid:1639784810.1002/ptr.178016397848
  21. 21. Martínez-Salgado, C., Eleno, N., Tavares, P., Rodríguez-Barbero, A., García-Criado, J., Bolaños, J.P., López-Novoa, J.M. (2002). Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation. Kidney Int. 62(5): 1682-1692. https://doi.org/10.1046/j.1523-1755.2002.00635.x PMid:1237196810.1046/j.1523-1755.2002.00635.x12371968
  22. 22. Bustos, P.S., Deza-Ponzio, R., Páez, P.L., Albesa, I., Cabrera, J.L., Virgolini, M.B., Ortega, M.G. (2016). Protective effect of quercetin in gentamicin-induced oxidative stress in vitro and in vivo in blood cells. Effect on gentamicin antimicrobial activity. Environ Toxicol Pharmacol. 48, 253-264. https://doi.org/10.1016/j.etap.2016.11.004 PMid:2784640810.1016/j.etap.2016.11.00427846408
  23. 23. Kim, J., Lee, Y., Koh, W.S., Kim, C., Choi, I.Y., Kwon, S.C., Lee, G.S., Han, J.Y., Lee, M. (2007). Genotoxicity assessment of HM10620 containing recombinant human interferon-alpha. Drug Chem Toxicol. 30(1): 83-95. https://doi.org/10.1080/01480540601017744 PMid:1736486610.1080/0148054060101774417364866
  24. 24. Bidgoli, S.A., Heshmati, M., Keyhan, H., Afshary, A. (2012). Genotoxicity assessment of recombinant human interferon gamma in human lymphocytes. JAASP 1(2):107-115.
  25. 25. Tsoncheva, V.L., Todorova, K.A., Ivanov I.G., Maximova, V.A. (2008). Influence of interferons on the repair of UV-damaged DNA. Z Naturforsch C J Biosci. 63(3-4): 303-307. https://doi.org/10.1515/znc-2008-3-423 PMid:1853347810.1515/znc-2008-3-42318533478
  26. 26. Hara, T., Koyama, K., Miyazaki, H., Ohguro, Y., Shimizu, M. (1977). Safety evaluation of KW-1062. I. Acute toxicity in mice, rats and dogs, subacute and chronic toxicity in rats (author’s transl). Jpn J Antibiot. 30(6): 386-407.
  27. 27. Steinbach, T.J., Patrick, D.J., Cosenza, M.E. (2019). Toxicologic pathology for non-pathologists. New York: Springer; Humana https://doi.org/10.1007/978-1-4939-9777-010.1007/978-1-4939-9777-0
  28. 28. Haitov, R.M., Ataullahanov, R.I., Allenov, S.N., Alyaev, Y.U.G., Balabolkin, I.I., Batkaev, E.A., Batkaeva, N.V., et al. (2014). Immunotherapy: a guide for physicians. Moskow: GEOTAR-Media [in Russian]
  29. 29. Selleri, C., Sato, T., Anderson, S., Young, N.S., Maciejewski, J.P. (1995). Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol. 165(3): 538-546. https://doi.org/10.1002/jcp.1041650312 PMid:759323310.1002/jcp.10416503127593233
  30. 30. Lin, F., Karwan, M., Saleh, B., Hodge, D.L., Chan, T., Boelte, K.C., Keller, J.R., Young, H.A. (2014). IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation. Blood 124(25): 3699-3708. https://doi.org/10.1182/blood-2014-01-549527 PMid:25342713 PMCid:PMC426398010.1182/blood-2014-01-549527426398025342713
  31. 31. Schroder, K., Hertzog, P.J., Ravasi, T., Hume, D.A. (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 75(2): 163-189. https://doi.org/10.1189/jlb.0603252 PMid:1452596710.1189/jlb.060325214525967
  32. 32. Murayama, T., Takahashi, N., Ikoma, N. (1996). Cytotoxicity and characteristics of mitomycin C. Ophthalmic Res. 28(3): 153-159. https://doi.org/10.1159/000267896 PMid:882917110.1159/0002678968829171
  33. 33. Pawlik, T.M., Keyomarsi, K. (2004). Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 59(4): 928-942. https://doi.org/10.1016/j.ijrobp.2004.03.005 PMid:1523402610.1016/j.ijrobp.2004.03.00515234026
  34. 34. Fingert, H.J., Chang, J.D., Pardee, A.B. (1986). Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res. 46(5): 2463-2467.
  35. 35. Wang, X.Y., Crowston, J.G., Zoellner, H., Healey, P.R. (2007). Interferon-alpha and interferon-gamma sensitize human tenon fibroblasts to mitomycin-C. Invest Ophthalmol Vis Sci. 48(8): 3655-3661. https://doi.org/10.1167/iovs.06-1121 PMid:1765273510.1167/iovs.06-112117652735
Language: English
Page range: 79 - 87
Submitted on: Sep 15, 2021
Accepted on: Feb 9, 2022
Published on: Mar 29, 2022
Published by: Ss. Cyril and Methodius University in Skopje
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2022 Sergey Shabunin, Vasilina Gritsyuk, Galina Vostroilova, Dmitriy Shabanov, Nina Khokhlova, Anastasiya Korchagina, published by Ss. Cyril and Methodius University in Skopje
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.